Unlisted
| Company Name | (주)모아라이프플러스 |
| English Name | MOA Life Plus Co. Ltd. |
| Business Reg. No. | 3148129870 |
| CEO | 한상진 |
| Address | 경기도 용인시 수지구 신수로 767 7층 (동천동, 분당수지유타워 지식산업센터) |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 701 |
| Main Products | 자궁경부상피이형증 치료제,자구경부전암 치료백신 연구개발/동물의약품 제조 |
| Established | 19991230 |
| Phone | 031-280-9650 |
| Website | www.bioleaders.co.kr |
| Regular Employees | 42persons |
| Corp. Reg. No. | 1601110091332 |
Venture Certified
| 연구개발기업 | 2001-03-30 ~ 2003-03-29 | 011535033301018 | 2001-03-30 |
| 연구개발기업 | 2003-03-30 ~ 2005-03-29 | 031535021400081 | 2001-03-30 |
| 연구개발기업 | 2005-03-30 ~ 2007-03-29 | 051522031500081 | 2001-03-30 |
| 연구개발유형 | 2007-03-30 ~ 2009-03-29 | 20070100652 | 2001-03-30 |
| 기술평가보증기업(기금) | 2009-03-30 ~ 2010-03-29 | 20090102832 | 2001-03-30 |
| 기술평가보증기업(기금) | 2010-03-30 ~ 2012-03-29 | 20100103133 | 2001-03-30 |
| 기술평가보증기업(기금) | 2012-03-30 ~ 2014-03-29 | 20120104263 | 2001-03-30 |
| 기술평가보증기업(기금) | 2014-03-30 ~ 2016-03-29 | 20140105260 | 2001-03-30 |
| 기술평가보증기업(기금) | 2016-03-30 ~ 2018-03-29 | 20160104025 | 2001-03-30 |
| 연구개발유형 | 2018-03-30 ~ 2020-03-29 | 20180103241 | 2001-03-30 |
| 연구개발유형 | 2020-03-30 ~ 2022-03-29 | 20200104625 | 2001-03-30 |
| 혁신성장유형 | 2022-03-30 ~ 2025-03-29 | 20220414030106 | 2001-03-30 |
| 혁신성장유형 | 2025-03-30 ~ 2028-03-29 | 20250408030074 | 2001-03-30 |
Revenue CAGR -46.3%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 156B | 182B | 220B | 1,012B |
| Operating Profit | -55B | -52B | -97B | -145B |
| Net Profit | -70B | 81B | -337B | -358B |
| Total Assets | 622B | 491B | 1,484B | 1,888B |
| Total Liabilities | 217B | 133B | 811B | 905B |
| Total Equity | 405B | 358B | 673B | 983B |
Operating Loss: Op. profit -55B
Debt Ratio Surge (+17pp YoY)
▼ 66.8%
▲ 43.4%
▼ 22.4%
▼ 35.5%
▲ 19.2%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 한상진 | 사내이사 | CEO | - |
| 윤상호 | 사내이사 | COO | - |
| 이건웅 | 사내이사 | CFO | - |
| 허익준 | 감사 | 감사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| Regular Employees | 42persons |
| CEO | 한상진 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 용인시",
"ceo_name": "한상진",
"certificate": [
{
"cert_number": "011535033301018",
"changes": "",
"disclosure_date": "2001-03-30",
"first_cert_date": "2001-03-30",
"no": "1",
"type": "연구개발기업",
"valid_period": "2001-03-30 ~ 2003-03-29"
},
{
"cert_number": "031535021400081",
"changes": "",
"disclosure_date": "2003-03-30",
"first_cert_date": "2001-03-30",
"no": "2",
"type": "연구개발기업",
"valid_period": "2003-03-30 ~ 2005-03-29"
},
{
"cert_number": "051522031500081",
"changes": "",
"disclosure_date": "2005-03-30",
"first_cert_date": "2001-03-30",
"no": "3",
"type": "연구개발기업",
"valid_period": "2005-03-30 ~ 2007-03-29"
},
{
"cert_number": "20070100652",
"changes": "",
"disclosure_date": "2007-03-26",
"first_cert_date": "2001-03-30",
"no": "4",
"type": "연구개발유형",
"valid_period": "2007-03-30 ~ 2009-03-29"
},
{
"cert_number": "20090102832",
"changes": "",
"disclosure_date": "2009-04-01",
"first_cert_date": "2001-03-30",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2009-03-30 ~ 2010-03-29"
},
{
"cert_number": "20100103133",
"changes": "",
"disclosure_date": "2010-04-01",
"first_cert_date": "2001-03-30",
"no": "6",
"type": "기술평가보증기업(기금)",
"valid_period": "2010-03-30 ~ 2012-03-29"
},
{
"cert_number": "20120104263",
"changes": "",
"disclosure_date": "2012-05-09",
"first_cert_date": "2001-03-30",
"no": "7",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-03-30 ~ 2014-03-29"
},
{
"cert_number": "20140105260",
"changes": "",
"disclosure_date": "2014-05-02",
"first_cert_date": "2001-03-30",
"no": "8",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-03-30 ~ 2016-03-29"
},
{
"cert_number": "20160104025",
"changes": "",
"disclosure_date": "2016-04-08",
"first_cert_date": "2001-03-30",
"no": "9",
"type": "기술평가보증기업(기금)",
"valid_period": "2016-03-30 ~ 2018-03-29"
},
{
"cert_number": "20180103241",
"changes": "",
"disclosure_date": "2018-03-27",
"first_cert_date": "2001-03-30",
"no": "10",
"type": "연구개발유형",
"valid_period": "2018-03-30 ~ 2020-03-29"
},
{
"cert_number": "20200104625",
"changes": "",
"disclosure_date": "2020-04-14",
"first_cert_date": "2001-03-30",
"no": "11",
"type": "연구개발유형",
"valid_period": "2020-03-30 ~ 2022-03-29"
},
{
"cert_number": "20220414030106",
"changes": "",
"disclosure_date": "2022-04-14",
"first_cert_date": "2001-03-30",
"no": "12",
"type": "혁신성장유형",
"valid_period": "2022-03-30 ~ 2025-03-29"
},
{
"cert_number": "20250408030074",
"changes": "",
"disclosure_date": "2025-04-08",
"first_cert_date": "2001-03-30",
"no": "13",
"type": "혁신성장유형",
"valid_period": "2025-03-30 ~ 2028-03-29"
}
],
"company_name": "주식회사 모아라이프플러스",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 16013874000,
"cost_of_sales": 15103307000,
"current_assets": 30690316000,
"current_liabilities": 21442573000,
"gross_profit": 6901030000,
"net_income": -28277277000,
"net_income_bs": -28277277000,
"non_current_assets": 35941882000,
"non_current_liabilities": 1340733000,
"non_operating_expenses": 23991688000,
"non_operating_income": 4526421000,
"operating_profit": -8812010000,
"revenue": 22004336000,
"sga_expenses": 15713039000,
"total_assets": 66632198000,
"total_equity": 43848891000,
"total_liabilities": 22783306000
},
"2023": {
"capital_stock": 16137521000,
"cost_of_sales": 12664212000,
"current_assets": 20898577000,
"current_liabilities": 12451906000,
"gross_profit": 5581105000,
"net_income": -8539824000,
"net_income_bs": -8539824000,
"non_current_assets": 25338497000,
"non_current_liabilities": 752711000,
"non_operating_expenses": 7453668000,
"non_operating_income": 3651356000,
"operating_profit": -4737512000,
"revenue": 18245316000,
"sga_expenses": 10318616000,
"total_assets": 46237075000,
"total_equity": 33032457000,
"total_liabilities": 13204617000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"main_products": "자궁경부상피이형증 치료제,자구경부전암 치료백신 연구개발/동물의약품 제조",
"phone": "031-280-****",
"years": [
2023,
2022
]
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |